SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000890163-21-000026
Filing Date
2021-08-02
Accepted
2021-08-02 14:13:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 s22-21918_cowen13g.htm SC 13G 38945
  Complete submission text file 0000890163-21-000026.txt   40420
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Recro Pharma, Inc. (Subject) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88042 | Film No.: 211135554
SIC: 2834 Pharmaceutical Preparations

Mailing Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022
Business Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022 2127027157
Cowen Prime Advisors LLC (Filed by) CIK: 0001875920 (see all company filings)

IRS No.: 270423711 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G